Literature DB >> 20590405

Hydroxamic acids (therapeutics and mechanism): chemistry, acyl nitroso, nitroxyl, reactive oxygen species, and cell signaling.

Peter Kovacic1, Corey L Edwards.   

Abstract

The hydroxamic acid functionality, a histone deacetylase inhibitor, has received much attention in relation to its physiological properties. This review mainly deals with the chemistry, mechanism, cell signaling, therapeutic properties, clinical trials, and toxicity. The chemistry provides insight concerning the mechanism. Acyl nitroso apparently is an intermediate, based on ease of oxidation of the parent and subsequent formation of nitroxyl (HNO) and nitric oxide. Acyl nitroso bears structural and electrochemical similarity to the phenylhydroxylamine-nitrosobenzene couple and to α-dicarbonyls. Acyl nitroso may be involved in electron transfer, reactive oxygen species formation and oxidative stress. Cell signaling plays a significant role in the biological action. The therapeutic properties are discussed with suberoylanilide hydroxamic acid attracting the most attention as an anticancer agent. Promise as a practical medicine for treatment of cancer is indicated by clinical trials. Toxicity is also included. Acyl nitroso, HNO, nitric oxide, and metal complexes of the parent drug are designated the main actors in the physiological effects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20590405     DOI: 10.3109/10799893.2010.497152

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  2 in total

1.  Preparation of bifunctional isocyanate hydroxamate linkers: Synthesis of carbamate and urea tethered polyhydroxamic acid chelators.

Authors:  Rasika Fernando; Jonathan M Shirley; Emilio Torres; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  Tetrahedron Lett       Date:  2012-11-21       Impact factor: 2.415

2.  Validation of HDAC8 Inhibitors as Drug Discovery Starting Points to Treat Acute Kidney Injury.

Authors:  Keith Long; Zoe Vaughn; Michael David McDaniels; Sipak Joyasawal; Aneta Przepiorski; Emily Parasky; Veronika Sander; David Close; Paul A Johnston; Alan J Davidson; Mark de Caestecker; Neil A Hukriede; Donna M Huryn
Journal:  ACS Pharmacol Transl Sci       Date:  2022-03-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.